BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23908512)

  • 1. Novel immunotherapies for rheumatoid arthritis.
    Richardson S; Isaacs J
    Clin Med (Lond); 2013 Aug; 13(4):391-4. PubMed ID: 23908512
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging immunotherapies for rheumatoid arthritis.
    Reynolds G; Cooles FA; Isaacs JD; Hilkens CM
    Hum Vaccin Immunother; 2014; 10(4):822-37. PubMed ID: 24535556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction: new treatment paradigms in rheumatoid arthritis.
    Putterman C
    Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3 Suppl):2-3. PubMed ID: 17491579
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapeutic approaches of rheumatic disorders.
    Houssiau FA; Lauwerys BR
    Acta Clin Belg; 1998 Jun; 53(3):155-61. PubMed ID: 9701849
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies for rheumatoid arthritis.
    Goldblatt F; Isenberg DA
    Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
    Leandro MJ
    Arthritis Res Ther; 2009; 11(5):128. PubMed ID: 19818166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis.
    Jung SM; Kim HS; Kim HR; Kim NY; Lee JH; Kim J; Kwok SK; Park KS; Park SH; Kim HY; Ju JH
    Int Immunopharmacol; 2014 Jul; 21(1):20-5. PubMed ID: 24752013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives].
    Jorgensen C
    Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor biology in experimental and clinical arthritis.
    Sfikakis PP; Kollias G
    Curr Opin Rheumatol; 2003 Jul; 15(4):380-6. PubMed ID: 12819464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.
    Cook AD; Visvanathan K
    Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunocorrection in rheumatoid arthritis].
    Seĭsenbanov ASh; Balabanova RM
    Ter Arkh; 1991; 63(11):125-8. PubMed ID: 1810046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New ways in the management of rheumatoid arthritis in Hungary].
    Gergely P; Poór G
    Lege Artis Med; 2007 Oct; 17(10):657-64. PubMed ID: 19227595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor α inhibitors in rheumatoid arthritis.
    Sakthiswary R; Shaharir SS; Mohd Said MS; Asrul AW; Shahril NS
    Int J Rheum Dis; 2014 Nov; 17(8):872-7. PubMed ID: 25292482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
    Kang SE; Park JK; Yoo HJ; Kang HS; Park YW; Park BC; Park JE; Lee EY; Lee EB; Song YW
    Transl Res; 2021 Jun; 232():75-87. PubMed ID: 33453429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.